|
|
Effect of 308 nm excimer laser+Tacrolimus in the treatment of adult facial vitiligo |
CHEN Jing LI Yu-liang PENG Sheng-zhi YI Sheng-gang PENG Yan-ping LIANG Qing |
Department of Dermatology, Pingxiang People′s Hospital |
|
|
Abstract Objective To explore the effect of 308 nm excimer laser+Tacrolimus in the treatment of adult facial vitiligo.Methods Seventy patients with facial vitiligo admitted to Pingxiang People′s Hospital, Jiangxi Province from January 2018 to December 2019 were selected and divided into reference group (n=35) and research group (n=35) according to the random throwing method. The reference group was treated with 308 nm excimer laser irradiation, and the research group was treated with 308 nm excimer laser+Tacrolimus, the total effective rate, intercellular adhesion molecule-1 (ICAM-1), melanocyte stimulating hormone (α-MSH), interleukin-17 (IL-17) indexes levels before and after treatment and incidence of adverse reactions were compared between the two groups. Results The total effective rate of the research group was 94.29%, which was higher than 77.14% of the reference group, and the difference was statistically significant (P<0.05). There were no statistical differences in the levels of ICAM-1, α-MSH and IL-17 before treatment between the groups (P>0.05). After treatment, ICAM-1 and IL-17 levels of the two groups were lower than those before treatment, and α-MSH level was higher than that before treatment; after treatment, the levels of ICAM-1 and IL-17 in the research group were lower than those in the reference group, and the level of α-MSH was higher than that in the reference group, the differences were statistically significant (P<0.05). The total adverse reaction rate in the research group was 11.43%, which was lower than that in the reference group (31.43%), the difference was statistically significant (P<0.05). Conclusion 308 nm excimer laser+Tacrolimus is effective in the treatment of adult facial vitiligo, and it has few adverse reactions, which has clinical promotion value.
|
|
|
|
|
[1] |
刘艳,温广东,马晓蕾,等.他克莫司软膏外涂联合308 nm准分子激光照射治疗白癜风的效果观察[J].蚌埠医学院学报,2019,44(8):1048-1050.
|
[2] |
周雪林.药物配合光疗调节白癜风患者血清IL-2、ICAM-1、α-MSH 水平[J].中外医学研究,2020,18(11):42-44.
|
[3] |
欧阳恒,杨志波,朱明芳.白癜风诊断与治疗[M].2 版.北京:人民军医出版社,2007.
|
[4] |
蔡素芬,罗权,黄久遂,等.他克莫司软膏治疗白癜风的临床疗效及对患者T 淋巴细胞水平的影响[J].皮肤性病诊疗学杂志,2019,26(3):144-149.
|
[5] |
修青,姜涛.他克莫司软膏联合窄谱中波紫外线治疗白癜风的效果分析[J].世界最新医学信息文摘,2019,19(43):222,226.
|
[6] |
李情,王西京.他克莫司与卡泊三醇联合激光治疗局限型白癜风疗效观察[J].实用中西医结合临床,2019,19(5):52-54.
|
[7] |
刘琼珍,许艳.药物联合便携式窄谱紫外光治疗白癜风疗效观察[J].皮肤病与性病,2019,41(2):232-233.
|
[8] |
王俊玲,蔡华.308 nm 准分子激光联合他克莫司软膏治疗面部白癜风的效果观察[J].黑龙江中医药,2019,48(2):252-253.
|
[9] |
刘斌.308 准分子激光治疗白癜风的临床疗效及其对皮肤黑色素水平和黑素细胞的影响[J].中国社区医师,2019,35(10):51,54.
|
[10] |
任学良.他克莫司软膏联合窄谱中波紫外线治疗白癜风的疗效探讨[J].中国医药指南,2019,17(8):11-12.
|
[11] |
周江峰,李君,赵勇,等.窄谱中波紫外线联合他克莫司软膏治疗白癜风的临床研究[J].中国医疗美容,2019,9(3):65-68.
|
[12] |
王晓燕,邹振.他克莫司联合308 nm 准分子激光对白癜风患者的作用探讨[J].世界最新医学信息文摘,2019,19(21):28-29.
|
[13] |
李宇飞.他克莫司软膏、卤米松乳膏联合308 准分子光治疗白癜风疗效观察[J].临床医药文献电子杂志,2018,5(93):12-13.
|
[14] |
杨惠.他克莫司治疗白癜风患者的疗效观察及对皮损处TNF-α 的影响分析[J].临床医药文献电子杂志,2018,5(51):48,50.
|
[15] |
张庆伟,王艳慧.308 nm 准分子激光联合他克莫司治疗稳定期头面部白癜风效果观察[J].山东医药,2016,56(18):107.
|
|
|
|